Assembly Biosciences, Inc.
HEPATITIS B CORE PROTEIN MODULATORS

Last updated:

Abstract:

The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.

Status:
Application
Type:

Utility

Filling date:

30 May 2019

Issue date:

30 Apr 2020